News and Events

Programs and providers of Obstetrics and Gynecology at Weill Cornell Medicine are often the focus of news stories and features appearing in major national media. We invite you to review some stories that typify the breakthrough accomplishments of our remarkable team and highlight the impact our care has had on patient’s lives.

Findings May Lead to Blood Test to Predict Risk of Postpartum Depression

postpartum depression

Women who go on to develop postpartum depression (PPD) may have characteristic levels of neuroactive steroids, molecules derived from the hormone progesterone, in their blood during the third trimester of pregnancy, according to a new study by researchers at Weill Cornell Medicine and the University of Virginia School of Medicine. These molecules influence the brain’s stress response and emotional regulation.

The findings, published Jan. 30 in Neuropsychopharmacology, suggest that this may provide a way to identify women at risk of PPD before symptoms start, allowing doctors to intervene earlier. Postpartum depression, severe depression that happens after giving birth, affects 10-15% of new mothers, causing emotional struggles that can impact both the parent and child for years. Symptoms include difficulty bonding with the baby, feelings of hopelessness and sadness, fatigue, loss of appetite, difficulty sleeping, to name a few.

Podcast: Vulvar Care for Children and Adolescents

In the latest episode of Kids Health Cast, Dr. Aimee Morrison highlights the importance of vulvar care for children and adolescents. She discusses the signs, symptoms, and normal changes associated with vaginal health through the life stages. She provides parents with guidance and reassurance to their daughters when it comes to this sensitive health topic. From basic hygiene tips to recognizing concerning changes, this is an essential guide for all parents seeking to support their children’s health. Listen to the episode here.

Learn more about the Kids Health Cast podcast here.

Innovators Encourage Scientists and Physicians to Dive into Technology Commercialization

A Caucasian man in light purple suit facing and talking to a woman with long brunette hair and waring a blue blazer

When Dr. Tamatha Fenster received a call from a young patient requesting a refill on her Oxycodone for pelvic pain, she was faced with a dilemma: letting the patient remain in pain or refill a prescription and perpetuate an opioid dependency.

With few other pain-relief options, she refilled the prescription. “I had to think of an alternative for pelvic pain for women,” said Dr. Fenster, assistant professor of clinical obstetrics and gynecology at Weill Cornell Medicine and an obstetrician and gynecologist at NewYork-Presbyterian/Weill Cornell Medical Center. And she did just that.

Dr. Fenster, along with other researchers and physicians, recounted their technology development and commercialization journeys at the annual Dean’s Symposium on Innovation and Entrepreneurship, hosted by Enterprise Innovation Dec. 18 in Uris Auditorium. In its eighth year, the symposium celebrates innovation and Weill Cornell Medicine’s entrepreneurial spirit, while encouraging and motivating the next generation of innovators, inventors and entrepreneurs.